At a glance
- Originator Abbott Laboratories
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections; Varicella zoster virus infections
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 13 Mar 1995 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
- 13 Mar 1995 No-Development-Reported for Varicella zoster virus infections in USA (Unknown route)